Is pathologic complete response a valid surrogate parameter of treatment efficacy in HER2 positive breast cancer patients undergoing primary chemotherapy plus trastuzamab?
Academic Article
Publication Date:
2005
CRIS type:
1.1 Articolo in rivista
List of contributors:
Berruti, Alfredo; Generali, D; Brizzi, Mp; Ardine, M; Dogliotti, L; Bottini, A.
Published in: